These two innovation stocks appear poised for robust growth over the next 20 years.
The rocket launch company competes with SpaceX and is growing quickly, but is it a good buy today?
One pundit tracking the company is particularly concerned about the performance of its foundational snacks business.
A significant shareholding is being unloaded to the public.
After yesterday's interest rate-fueled surge, another analyst is stepping to the sidelines.
/Elon%20Musk%2C%20founder%2C%20CEO%2C%20and%20chief%20engineer%20of%20SpaceX%2C%20CEO%20of%20Tesla%20by%20Frederic%20Legrand%20-%20COMEO%20via%20Shutterstock.jpg)
With EV giant Tesla on the brink of launching its game-changing Robotaxi next month, what stance should investors adopt ahead of this major event?
/Raymond%20James%20Financial%2C%20Inc_%20location-by%20Jonathan%20Weiss%20via%20Shutterstock.jpg)
Although Raymond James Financial has underperformed the Dow Jones Industrials Average, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
For Immediate ReleasesChicago, IL – September 18, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...
One of the leading providers of semiconductor memory solutions, Micron Technology, Inc. MU, recently flashed a bearish chart pattern after an eminent investment bank cut off its price target. So, what’s...
/GE%20HealthCare%20Technologies%20Inc%20sign%20on%20building%20-by%20Poetra%20RH%20via%20Shutterstock.jpg)
GE HealthCare has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects.